Engineering CAR-NK cells: how to tune innate killer cells for cancer immunotherapy

Cell therapy is an innovative approach that permits numerous possibilities in the field of cancer treatment. CAR-T cells have been successfully used in patients with hematologic relapsed/refractory. However, the need for autologous sources for T cells is still a major drawback. CAR-NK cells have eme...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, Dayane, Ebrahimabadi, Sima, Gomes, Kauan Ribeiro de Sena, de Moura Aguiar, Graziela, Cariati Tirapelle, Mariane, Nacasaki Silvestre, Renata, de Azevedo, Júlia Teixeira Cottas, Tadeu Covas, Dimas, Picanço-Castro, Virginia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
T Cell-Targeted Approaches to Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327111/
https://www.ncbi.nlm.nih.gov/pubmed/35919494
http://dx.doi.org/10.1093/immadv/ltac003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327111/
https://www.ncbi.nlm.nih.gov/pubmed/35919494
http://dx.doi.org/10.1093/immadv/ltac003

Ejemplares similares